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Abstract 
Little is known about the functions of two different β5 integrin: repeated-FNK 
(FNKFNK764-769) and single-FNK (FNK764-766) amino acid sequence in the cytoplasmic 
domain. We examined whether it occurred as germ line mutation or somatic mutation 
associated with neoplastic transformation, and whether there is functional alteration. Among 6 
culture cell lines only KATO-III cells have the single-FNK β5 sequence, while other cell lines 
do not. The single-FNK β5 was found in 9 of 79 patients with colon carcinoma, but no 
somatic mutations were detected in cancer tissues. CHO cells were transformed with 
expression vectors containing single-FNK or repeated-FNK β5 cDNA, which were derived 
from KATO-III cells. CHO cells transfected with single-FNK and with repeated-FNK showed 
similar adhesiveness to and proliferative activity on vitronectin substrates.  
 





The members of the integrin family are characterised by the ability to dynamically 
regulate their ligand binding affinity; integrin-mediated cell anchorage to the extracellular 
matrix has also been shown to induce signal transduction pathways (Hynes, 1992; Guadagno 
et al., 1993; Juliano and Haskill, 1993). The cytoplasmic sequences of the integrins appear to 
be involved in signalling events (O’Toole et al., 1994), and experimental studies have 
revealed a crucial role of the cytoplasmic domains in maintaining the proteins’ functions 
(Stephens et al., 1993). In addition, it was reported that alternative splicing variants of β 
subunits in α6, β1, β3 and αIIb usually occur in cytoplasmic domains, with many of the 
variants being functionally inactive. 
 The αvβ5 integrin is expressed by most epithelial cells (Pasqualini et al., 1993). Its 
function differs from that of the major vitronectin receptor, αvβ3, and the cytoplasmic 
domain of β5 can transduce adhesion information to subsequent signalling pathways 
(Leavesly et al., 1992; Pasqualini and Hemler 1994). The cDNA sequence of the β5 subunit 
from the UCLA-P3 human lung carcinoma cell line (McLean et al., 1990), and that obtained 
from a thymic epithelial cDNA library (Ramaswamy and Hemler, 1990) have a repeated-FNK 
sequence (FNKFNK764-769) in the cytoplasmic domain. Moreover, a different β5 sequence has 
been reported by Suzuki et al. (1990) in an uncharacterised cell line in which FNK767-769 was 
deleted, resulting in a single FNK sequence. Although Ramaswamy and Hemler (1990) 
suggested that the repeated FNK sequence was the prototype of β5, they identified five of 
eight clones in a λgt11 thymic epithelial cDNA library that lacked the second FNK. In 
addition, other types of heterogeneity were found at positions 336-338, 379-381 and 708. 
These findings indicate molecular polymorphism of the β5 integrin subunit, whereas the 
cytoplasmic domains of other integrin subunits are highly conserved, except for alternative 
splicing. However, nothing is known about the significance of the polymorphism of β5.  
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 In this report, we examined the incidence of the variant type β5 integrin containing 
single FNK sequence in using colon tissues, and examined whether it occurred as somatic 
mutation in carcinoma tissue. Furthermore, we tried to clarify whether it had functional 
alteration. Here, we report that adhesiveness and proliferative activity of the variant type, 
which appear in 10% of the population, are similar to those of the prototype β5 integrin. 
2. Materials and Methods 
2.1 Carcinoma cell lines 
 A variety of cell lines, including the oral squamous carcinoma lines OSC-19 and 
HSC-3 (Kawahara et al., 1995), the lung carcinoma lines Calu-1, VMRC-LCP, ACC-LC-73 
(Suzuki et al., 1993) and LU65, and the gastric carcinoma cell line KATO-III (Sekiguchi, 
1978), were used in the present study. Sub-confluent cultures were used to examine mRNA 
expression. All cell lines were maintained in Eagle’s minimum essential medium containing 
10% foetal bovine serum (Gibco BRL, Rockville, MD, USA). HSC-3, VMRC-LCP, LU65 
and KATO-III were obtained from the Japanese Cancer Resource Bank, and ACC-LC-73 and 
Calu-1 were provided by Dr. T. Takahashi (Aichi Cancer Institute, Japan).  
2.2 Reverse transcription (RT) - PCR 
 Total cellular RNA was extracted by the guanidinium isothiocyanate method 
(Chomozynski et al., 1987) using a Total RNA Separator Kit (Clontech Laboratories, Inc., 
Palo Alto, CA, USA). Poly (A+) mRNA was obtained from the cultured carcinoma cells by 
using an oligo-dT column (Poly (A) Quick Kit, Stratagene, La Jolla, CA, USA). First-strand 
cDNA was synthesised using AMV reverse transcriptase (Takara Bio, Ohtsu, Japan). The 
resulting cDNA was used for PCR amplification of an intracytoplasmic domain of β5 
integrins, using primer pairs that amplify a 219-bp fragment encoding the cytoplasmic region 
of β5, i.e., B5VNR5, 5'-2514TGTGGTCGGTAGCATCCTCC2533-3' and B5VNR3, 5'-
2765CCCGCTCCAGCCCCTCGGAG2746-3', according to the sequence of Hemler et al. 
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(EMBL/GenBank/DDBJ, accession no. X53002). The PCR conditions were as follows: 94°C 
for 30 s, 55°C for 30 s, 72°C for 30 s, and a final extension at 72°C for 5 min. The PCR 
products were electrophoresed on agarose gels, which were stained with ethidium bromide 
before or after electrophoresis. HaeIII fragments of φX174 replicative form DNA were used 
as molecular size markers (Toyobo, Osaka, Japan).  
2.3 PCR/Single-strand conformation polymorphism (SSCP) analysis 
 SSCP analysis was performed as described previously (Akasofu and Oda, 1995). 
DNA was subjected to PCR using a set of primers, B5VNR5 and B5VNR3, labelled with [γ-
32P] ATP (7,000 Ci/mmol, 160 mCi/ml, ICN, Costa Mesa, CA, USA) by the polynucleotide 
kinase reaction (Takara). The PCR products in formamide were heated to 80°C for 5 min, and 
then loaded onto gels. Polyacrylamide gel electrophoresis was performed at 40 watts for 3 h at 
4°C. The gels were dried on filter paper and exposed to X-ray film at –80°C for 1-12 h with 
an intensifying screen. 
2.4 S1 nuclease digestion 
 After electrophoresis, bands were cut out of the agarose gels and the DNA was 
extracted using filtration tubes (Suprec-01, Takara). The purified samples were incubated for 
30 min at 37°C with 750 U of S1 nuclease (Takara) in 200 µl of S1 nuclease solution (30 
mM sodium acetate, pH 4.6, 280 mM NaCl and 1 mM ZnSO4). After ethanol precipitation, 
the samples were electrophoresed in 2% agarose gels, and then stained with ethidium bromide. 
2.5 Direct sequencing 
 After PCR and electrophoresis on agarose gels, the bands were cut out and extracted 
using filtration tubes. The amplified strands were labelled with fluorescein by the 
dideoxynucleotide chain termination method using a DyeDeoxy Terminator Cycling Kit 
(Perkin-Elmer, Foster City, CA, USA). DNAs were analysed with an autosequencer and a 373 
DNA sequence analyser (Perkin-Elmer). 
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2.6 TA cloning 
 The PCR products were subcloned into vectors by the TA cloning method (Clark, 
1988) using a TA cloning kit (Invitrogen Corp., Carlsbad, CA, USA). Briefly, fresh PCR 
products amplified using Taq polymerase were ligated into linearised pCR2.1 (Invitrogen) 
using T4 DNA ligase. The ligated vectors were transformed into competent INVαF7 cells and 
grown overnight on LB agar plates containing ampicillin and X-gal. Blue-white screening 
was performed for inserts. The ligated clones were purified and the inserts were sequenced 
using the M13(-20) forward primer and a DyeDeoxy Terminator Cycling Kit.  
2.7 Tissue samples 
 Tissue samples were obtained from 33 patients with colon carcinoma, who 
underwent surgery at Kanazawa University Hospital. Tumour and non-tumour tissues were 
dissected immediately after operation. Genomic DNA was extracted from the tissues by the 
standard procedure using a DNA extraction kit (Stratagene). Informed consent was obtained 
from all patients enrolled in the study.  
2.8 Expression vector and transfection 
 β5 Integrin cDNA (repeated FNK) inserted into the expression vector pcDNA1.1Neo 
was kindly provided by Dr. D.A. Cheresh (The Scripps Research Institute, La Jolla, CA, 
USA). β5 cDNA was cut out of the vector with BamHI and HindIII and reinserted into the 
permanent expression vector, pcDNA3.1 (Invitrogen). The resultant vector, 
FNKFNK/pCDNA3.1, was transfected into CHO-K1 cells by lipofection using Effectene 
Transfection Reagent (QIAGEN, Chatsworth, CA, USA). Transfected cells were cultured in 
Ham’s F12 medium containing 10% foetal bovine serum and 400 µg/ml G418 (Sigma, St. 
Louis, MO, USA) for 1 week. Surviving cells were harvested and cloned on 96-well plates. 
2.9 Immunoprecipitation 
 Cell-surface proteins were biotinylated with ECL Biotinylation Reagents (Amersham 
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Pharmacia Biotech, Piscataway, NJ, USA). Cell lysates obtained with cell lysis buffer (250 
mM NaCl, 25 mM Tris-HCl, pH 7.5, 5 mM EDTA, 0.5% NP-40, 1 mM PMSF, 2 µg/ml 
aprotinin and 1 µg/ml leupeptin) were centrifuged and the supernatants were reacted with 
1 µg of anti-β5 integrin antibody (clone IA-IV5, provided by Dr. Hemler) and with 100 µl of 
protein G-Sepharose (Amersham Pharmacia Biotech) for 3 h at 4°C. After washing 6 times 
with cell lysis buffer, sodium dodecyl sulphate sample buffer (62.5 mM Tris-HCl buffer, pH 
6.8, 2% sodium dodecyl sulphate, 10% glycerol, 0.1% bromophenol blue, 6% 
mercaptoethanol) was added to the gel, and then heated at 95°C for 5 min. Supernatants were 
subjected to 6% polyacrylamide gel electrophoresis and transferred onto polyvinylidene 
fluoride membranes (Perkin-Elmer). The membranes were reacted with peroxidase-
conjugated streptavidin. Visualisation was performed using a chemiluminescence system 
(ECL Western Blotting Detection Reagent, Amersham Pharmacia Biotech). 
2.10 Adhesion assay 
 Flat-bottomed polystyrene, 24-well plates (Falcon Products, Oxford, CA, USA) were 
coated with 10 µg/ml vitronectin purified from human plasma (Kawahara et al., 1995) in 
phosphate-buffered saline overnight at 4°C. The wells were then blocked with 0.5% bovine 
serum albumin overnight at 4°C. Then, 50,000 cells in serum-free medium were loaded onto 
ligands and incubated in a CO2 incubator in quadruplicate. Non-adherent cells were removed 
by gentle washing with serum-free medium five times at room temperature. The status of 
adherent and non-adherent cells after washing was checked by a light microscopy, and the 
remaining adherent cells were quantified by MTT assay (Mossman, 1983). After removal of 
non-adherent cells, the plates were filled with 200 µl medium and 30 µl 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT, Sigma) solution (5 mg/ml in 
distilled water), then incubated for 3 hours at 37 ºC.  After removing the solution the 
insoluble dye product was solubilized with 200 µl dimethylsulfoxide, and the absorbance at 
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492 nm was measured. 
2.11 Statistics  
 Student’s t test was used for comparison of the averages of two groups. Two-way 
analysis of variance was used for comparison of kinetic data between two groups.  
 
3. Results 
3.1 Heterogeneity of the cytoplasmic domain of the β5 subunit in Kato-III cell cDNA 
 First, we examined the expression of β5 mRNA by RT-PCR with the primer pair 
B5VNR5 and B5VNR3. All cells examined showed a single band at 219 bp when DNA was 
run on an agarose gel containing ethidium bromide (Fig. 1A). Amplified products from all 
cells were sequenced directly. The deduced amino acid sequence of β5 at positions 764 to 769 
in seven of the eight carcinoma cell lines examined was FNKFNK764-769. This sequence, 
reported previously by McLean et al. (1990) and Ramaswamy and Hemler (1990), is referred 
to as the prototype sequence. The sequence pattern of the PCR-amplified β5 of KATO-III 
showed a double peak downstream of nucleotide 2,553 using the sense primer (Fig. 1B), and 
upstream of nucleotide 2,562 using the antisense primer, indicating the presence of multiple 
components with the same sequence between position 2,553 and 2,562. This pattern was 
considered to reflect the presence of a species with a 9-base deletion at base 32 upstream from 
the stop codon, which is consistent with the sequence reported by Suzuki et al. (1990). The 9-
base deletion results in deletion of the amino acid sequence FNK767-769. To confirm the 
presence of the two components, we performed SSCP analysis. β5 cDNAs from KATO-III, 
LU65 and Calu-1 cells were amplified by PCR and electrophoresed. The PCR products of 
KATO-III showed four bands, two of which were at the same positions as those of Calu-1 and 
LU65 cells (Fig. 1C), indicating the presence of a mixture of PCR products with two different 
sequences. Subsequently, we subcloned the PCR products with a TA cloning system. One 
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colony showed the prototype sequence (Fig. 1D, top), and another showed the 9-base deletion 
(Fig. 1D, bottom).  
3.2 Double bands appeared in heterozygous expression 
 Furthermore, we found that the PCR products of KATO-III cDNA had double bands 
around 219 bp that were separated by more than the size of the 9-bp deletion on agarose gels 
stained with ethidium bromide after electrophoresis (Fig. 2A). All cell lines except KATO-III 
showed single bands. The difference between the double bands seemed to be larger than 9 bp, 
and the DNAs extracted from the upper and lower bands were sequenced separately. 
Surprisingly, they had the same sequence patterns, showing that they contained mixtures of 
DNA (Fig. 2B). To address this problem, we considered a mismatch and match hypothesis. 
That is, both the upper and lower bands were composed of a mixture of the prototype and the 
deletion type, but the DNA of the upper band was composed of only double-stranded 
mismatched DNA whose secondary structure formed a loop, resulting in a lower 
electrophoretic mobility. On the other hand, the lower bands were composed of non-
mismatched double-stranded DNA of prototype and mutant type that showed no mobility 
differences under the electrophoretic conditions used. To test this hypothesis, S1 nuclease was 
used to digest single-stranded, but not double-stranded, DNA, as occurs in the non-hybridised 
portions of a loop in mismatched DNA. After S1 nuclease digestion, the upper band showed a 
shift in mobility to the same position as the lower band, while the position of the lower band 
was not altered (Fig. 2C). 
3.3 Intron sequence of the cytoplasmic domain of β5 
 We investigated whether the 9-base deletion in the cDNA was caused by a deletion 
in the genomic DNA, alternative splicing or mutation at the exon-intron boundary. For this 
purpose, it was necessary to analyse the genomic DNA sequence and to establish the location 
and sequence of the intron in the cytoplasmic domain of β5. We assumed that all α and β 
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integrin subunits have introns at similar positions (McLean et al., 1990), and hence we 
examined the intron position at a location corresponding to that of β3 and αIIb (van 
Kuppevelt et al., 1989; Prandini et al., 1988), near the sequence encoding FNK. Genomic 
DNA of Calu-1 cells was amplified using primers B5VNR5 and B5VNR3, which amplify a 
cDNA fragment of 219 bp. The PCR product contained about 890 bp, of which 670 bp were 
assumed to be the intron. The PCR products were sequenced and we determined a partial 
sequence of the intron. The results indicated that the intron was located 55 bp upstream of the 
first nucleotide corresponding to FNK. We prepared a newly designed primer spanning the 
intron sequence, B5INT1U, 5'-ACTGTGTCCTCATCTCTTCC-3', and used it, together with 
the antisense primer B5VNR3, to amplify the variable sites of the genomic DNA (Fig. 3). 
With the exception of KATO-III, the PCR products of 6 carcinoma cell lines showed single 
bands at 159 bp. The PCR products of KATO-III appeared as two bands separated by more 
than 9 bp under the same conditions (data not shown). The PCR products of KATO-III were 
subcloned into pCR2.1. One clone had the same sequence as Calu-1 (repeated FNK), and 
another clone had a 9-base deletion in the exon sequence (single FNK). 
3.4 Prevalence of the single-FNK β5 in cancer and non-cancer tissues 
It is not known whether the 9-base deletion represents a somatic mutation occurring in the 
course of malignant transformation or a germ line mutation. Somatic mutation seems likely, 
because the single FNK sequence detected by Suzuki et al. (1990) and by us was present in 
carcinoma cells. On the other hand, Ramaswamy and Hemler (1990) identified five of eight 
clones in a λgt11 thymic epithelial cDNA library that lacked the second FNK. Hence, the 
protein with a single FNK may be a genetically determined variant of the β5 subunit. The 
observation that heterogeneous genomic DNA, including partial deletion, led to two fully 
separated electrophoretic bands provides a powerful means for detecting the heterozygous β5 
gene. Genomic DNA was extracted from colon cancer tissues from 89 patients, and the β5 
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integrin gene encoding the cytoplasmic domain was amplified with B5INT1U and B5VNR3. 
Seventy-nine cases showed a single band migrating to a position corresponding to 159 bp on 
agarose gel electrophoreses (homozygous), while double bands around this position were 
detected in 9 cases (11%) that were considered heterozygous in the β5 integrin gene (Fig. 4A). 
We further examined genomic DNA of non-cancer tissues. Heterozygous β5 in non-cancer 
tissues was only detected in the cases in which cancer tissues were also heterozygous (Fig. 
4B), indicating the absence of somatic mutation associated with neoplastic transformation. 
3.5 Transformation of CHO cell by single-FNK β5 and repeated-FNK β5 
As the function of β5 has been examined using repeated-FNK β5 (Pasqualini et al., 1993; 
Pasqualini and Hemler, 1994), it is necessary to determine whether single-FNK β5 has the 
same function as repeated-FNK β5. To address this question, single-FNK β5 and repeated-
FNK β5 were transfected into CHO cells. To obtain a full-length single-FNK β5 cDNA, a 
portion of β5 cDNA of KATO-III containing the sequence corresponding to the single FNK 
subcloned into pCR2.1 was used. The subcloned DNA containing the single FNK sequence 
was truncated with BspHI and XbaI. The portion of cDNA containing repeated-FNK was cut 
out of the expression vector FNKFNK/pcDNA3.1 by digestion with the same restriction 
enzymes and the single-FNK sequence was reinserted (FNK/pcDNA3.1). FNK/pcDNA3.1 
and FNKFNK/pcDNA3.1 were transfected into CHO cells, and clones were selected. To 
confirm transfection of FNK/pcDNA3.1 and FNKFNK/pcDNA3.1, genomic DNA and RNA 
were extracted from the transfected CHO cells. PCR using primers to amplify β5 cDNA 
showed corresponding bands in CHO cells transfected with FNKFNK/pcDNA3.1 and with 
FNK/pcDNA3.1, but not in non-transfected CHO cells (Fig. 5A). RT-PCR using primers that 
amplify β5 cDNA also showed the corresponding bands in transfected CHO cells (Fig. 5B). 
Surface expression of β5 in the transformed cells was confirmed by immunoprecipitation 
using biotinylated cell-surface proteins (Fig. 5C). To determine the adhesiveness of the 
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transformants to vitronectin, the kinetics of adhesion of CHO cells transfected with 
FNKFNK/pcDNA3.1 and with FNK/pcDNA3.1 were examined. The results showed partial 
adhesion of the cells to vitronectin at 10, 20 and 30 min, and no significant difference was 
detected in adhesiveness (Fig. 6A). We also examined proliferative activity on vitronectin for 
5 days. Cells suspended in serum-free medium were loaded onto vitronectin-coated dishes, 
and incubated for 5 days in a CO2 incubator at 37°C. Cells were harvested with 0.25% 
trypsin/EDTA, and counted with a hemocytometer under a light microscope. There was no 




KATO-III cells were confirmed to contain two distinct β5 sequences, as described previously 
(McLean et al., 1990; Ramaswamy and Hemler, 1990; Suzuki et al., 1990). However, no 
information is available about the significance of this polymorphism of β5. First, we 
investigated whether deletion of one FNK sequence in cDNA was caused by deletion in the 
genomic DNA, alternative splicing or mutation at the exon-intron boundary. Our results 
indicated that the polymorphism is due to a 9-base deletion in the genomic DNA. The single-
FNK β5 was concluded to be a genetically determined variant of the prototype β5 subunit. 
This variant type was shown to be expressed as a cell-surface protein, which might associate 
with αv integrin subunit to form a heterodimer. We further found that cells bearing the variant 
had similar characteristics with regard to adhesiveness and proliferation to cells bearing the 
prototype β5.  
 The variant differs in the cytoplasmic domain, which is the functionally crucial 
portion of integrin. The cytoplasmic sequences of the integrins are involved in the bi-
directional signalling events (O’Toole et al., 1994; Hynes et al., 2002). Src kinase 
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constitutively binds to the cytoplasmic domain of integrin β3 and the binding of integrin to 
extracellular ligands triggers outside-in signals (Arias-Salgado et al., 2003). The cytoplasmic 
domain of integrin also regulates inside-out signalling. Conformational change of 
extracellular domain is induced by the interaction of α and β at those cytoplasmic domains 
(Takagi et al., 2002), and the talin can directly activate integrins by binding to the β subunit at 
the cytoplasmic domain (Vinogradova et al., 2002). Patients with Glanzmann thrombasthenia 
were detected in β3 subunit of the cytoplasmic domain (Chen et al., 1992) and mutation of β2 
in th cytoplamic domain causes leukocyte adhesion deficiency (Anderson et al., 1987).  
Experimental study showed that deletion or substitution of one amino acid results in loss of 
integrin function (Reszka et al., 1992; Stephens et al., 1996; Languino and Ruoslahti, 1992; 
Meredith et al., 1995), and conversely activates integrin function constitutively (Hughes et al., 
1996). In addition, it has been reported that alternative splicing variants of β subunits, which 
were functionally inactive, occur in the cytoplasmic domains. Thus, a single amino acid 
substitution in the cytoplasmic domain can cause loss of function, and the variant type lacks 
three amino acids. Therefore, we initially considered that loss of function was likely. 
However, this was not the case. Studies of the cytoplasmic domain of avian β1 (Reszka et al., 
1992) identified three potentially important regions, designated cyto-1, cyto-2 and cyto-3, 
with the sequences HDRREFAKFEKE, NPIY and NPKY, respectively. These sequences are 
conserved in the β1, β2, β3, β5, β6 and β7 integrin subunits. When β1D, a variant of β1A that 
contains cyto-2 and cyto-3, was transfected into CHO cells, no alterations were observed in 
adhesiveness or tyrosine phosphorylation (Belkin et al., 1996), whereas β1B and β1C, which 
lack cyto-2 and cyto-3, were shown to be functionally inactive (Languino and Ruoslahti, 
1992; Meredith et al., 1995). Furthermore, cyto-2 and/or cyto-3 have been shown to be 
important for adhesiveness (Reszka et al., 1992; O’Toole et al., 1995). The NKSY sequence 
of β5 integrin is a motif corresponding to cyto-3 at six residues upstream from the N-terminus. 
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The deletion of one FNK converts FNKFNKSYN to FNKSYN, thus conserving the cyto-3 
sequence. This may be why the single-FNK β5 variant retains full functionality.
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Figure legends 
Fig. 1. Heterozygous β5 in KATO-III. A. RT-PCR using primers that amplify the cytoplasmic 
domain of β5. The PCR products were run on 2% agarose gels containing 0.1% ethidium 
bromide. The PCR product was seen as a single band of around 219 bp. B. 
Electrophoretograms of PCR products of KATO-III. Direct sequencing was performed by the 
dideoxynucleotide chain termination method. Double peaks appeared after the CAA sequence 
(indicated by arrows), which suggested the presence of a mixture of FNKFNK β5 and FNK 
β5 with a deletion of 9 bp, TTCAACAAA. C. Single-strand conformational polymorphism 
analysis of heterozygous amplified DNA. Four bands were detected in the PCR product of β5 
of KATO-III cells, whereas only two bands were found for Calu-1 and LU65 cells. D. The 
PCR product was subcloned using the TA-cloning method. One clone showed the sequence of 
FNK β5, and another showed the sequence of FNKFNK β5. 
Fig. 2. Analysis of heterozygous β5 showing double bands. A. RT-PCR using primers that 
amplify the cytoplasmic domain of β5. After electrophoresis, the agarose gel was stained with 
ethidium bromide solution. The PCR product of KATO-III was seen as double bands around 
219 bp, with an apparent difference of 20-30 bp. B. Electrophoretograms of PCR products of 
KATO-III extracted from the agarose gel. PCR products were extracted from the upper and 
lower bands, and were sequenced by the dideoxynucleotide chain termination method. Both 
electrophoretograms showed double peaks after the CAA sequence, marked by arrows, which 
indicated a mixture of FNKFNK β5 and FNK β5. C. The mismatch-match hypothesis was 
tested using S1 nuclease, which digests single-stranded DNA. DNAs were extracted from the 
upper and lower bands of the KATO-III double bands (Mix). After S1 nuclease treatment, the 
DNA of the upper band showed an electrophoretic mobility shift to the position of the lower 
band (UP). The position of the lower band did not change after S1 nuclease digestion (LW). 
NT, PCR product of KATO-III β5; M, molecular size standard (φ174 HaeIII fragments). D 
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and E. Biophysical analysis of the mismatch-match hypothesis. DNAs were extracted from 
the upper band (UP1) and lower band (LW1) of KATO-III without denaturation. Both DNAs 
were denatured by heating to 96°C, and cooled rapidly (UP2, LW2) or gradually to allow 
renaturation (UP3, LW3). Absorbance at 260 nm was determined (D), and the DNAs were 
subjected to 2% agarose gel electrophoresis (E).  
Fig. 3. Partial sequence of the intron in the cytoplasmic domain of β5 in Calu-1 cells. Primers 
that amplified the FNKFNK (bold) sequence of genomic DNA are underlined. The sequence 
deleted in FNK β5, AGTTCAACA, is boxed. 
Fig. 4. Heterozygous β5 in cancer and non-cancer tissues. Cancer tissues (cases 11-19) and 
the corresponding non-cancer tissues were examined to determine the prevalence of FNK β5. 
PCR analysis with the primer pair that amplified genomic DNA containing the sequence 
encoding FNKFNK showed double bands in both the cancer (A) and non-cancer tissues from 
case 15 (B), indicating heterozygosity in β5 integrin. The markers were PCR products 
produced with the same primers using pCR2.1 with the FNKFNK β5 insert (M1) and pCR2.1 
with the FNK β5 insert (M2) as the template. 
Fig. 5. Characterisation of CHO cells transfected with FNK β5 and FNKFNK β5. Genomic 
DNA (A) and RNA (B) were extracted from non-transfected CHO (lanes 1), FNKFNK 
β5/CHO (lanes 2), and FNK β5/CHO (lanes 3). DNA or RNA was amplified by PCR or RT-
PCR using primers that amplify the FNK portion. M, molecular size standard (φ174 HaeIII 
fragments). (C) Immunoprecipitation using anti-β5 antibody from cells in which surface 
protein was labelled with biotin. Immunoprecipitated protein from non-transfected CHO (lane 
1), FNKFNK β5/CHO (lane 2) and FNK β5/CHO (lane 3) was electrophoresed, transferred 
onto a PVDF membrane, reacted with streptavidin-HRP, and visualised by 
chemiluminescence. M, molecular size marker. 
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Fig. 6. Adhesiveness and proliferation of FNKFNK β5/CHO cells and FNK β5/CHO cells. 
(A) FNKFNK β5/CHO cells and FNKβ5/CHO cells were loaded onto vitronectin-coated 24-
well dishes. Non-adherent cells were removed by gentle washing at 10, 20 and 30 min and the 
remaining adherent cells were quantified by MTT assay. The kinetics of adhesion of 
FNKFNK β5/CHO cells were compared with those of FNKβ5/CHO cells using two-way 
analysis of variance (P>0.05).  (B) FNKβ5/CHO cells and FNKFNKβ5/CHO cells were 
loaded onto vitronectin-coated dishes 3.5 cm in diameter, and cultured for 5 days in a CO2 
incubator. Cells were dispersed with trypsin, and counted using a haemocytometer. Each bar 
shows the mean ± standard deviation of quadruplicate determinations. Student’s t test was 




















































































































AGTTTGCAAA GTTTCAGAGC GAGCGATCCA GGGCCCGCTA TGAAATGGTA AGCACGTGGG AAATGGGAAG CAGAGGAGAC
E  F  A  K   F  Q  S   E  R  S   R  A  R  Y   E  M
TTCAAGCTCA GAGGCGTGGT TGAGTTCAGC GGTATGTTAG CAATAGAGGC CACTAATGTC TTTGGCATTA ----------
-------------------TT TGAGTGTGTG AGCTAACACT GTGTCCTCAT CTCTTCCCCG CCGTGTTCTG TAGGCTTCAA
B5INT1U A  S
ATCCATTATA CAGAAAGCCT ATCTCCACGC ACACTGTGGA CTTCACCTTC AACAAGTTCA ACAAATCCTA CAATGGCACT
N  P  L  Y   R  K  P   I  S  T   H  T  V  D   F  T  F   N  K  F   N  K S  Y   N  G  T
GTGGACTGAT GTTTCCTTCT CCGAGGGGCT GGAGCGGGGA TCTGATGAAA AGGTCAGACT GAAACGCCTT GCACGGCTGC
V  D  J                  B5VNR3
A. Cancer tissue
B. Non-cancer tissue
11 13 14 15 16 17 18 19M1 12M2
11 13 14 15 16 17 18 19M1 12M2
B.
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